Koyfin Home > Directory > Health Care > Adamas Pharma > Return on Equity %

Adamas Pharma Return on Equity % Chart (ADMS)

Adamas Pharma annual/quarterly Return on Equity % from 2013 to 2020.
  • Adamas Pharma Return on Equity % for the quarter ending June 06, 2020 was 209.94 a 268.27% increase of 563.22 year over year
  • Adamas Pharma Return on Equity % for the last 12 months ending June 06, 2020 was -851.33 a 80.56% decrease of -685.85 year over year
  • Adamas Pharma Annual Return on Equity % for 2019 was -236.39 a 28.96% decrease of -68.46 from 2018
  • Adamas Pharma Annual Return on Equity % for 2018 was -167.94 a 46.26% decrease of -77.68 from 2017
  • Adamas Pharma Annual Return on Equity % for 2017 was -90.25 a 46.42% decrease of -41.89 from 2016
Other Margins & Efficiency Metrics:
  • Adamas Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-187m a 135.57% decrease of -254m year over year
  • Adamas Pharma Return on Capital % for the quarter ending September 09, 2018 was -29.66 a -68.05% increase of 20.18 year over year
View Chart On Koyfin

Quarterly ADMS Return on Equity % Data

06/2020209.94
03/2020795.32
12/2019-978.58
09/2019-353.28
06/2019-186.62
03/2019-154.27
12/2018-113.11
09/2018-103.21
06/2018-87.12
03/2018-118.68

Annual ADMS Return on Equity % Data

2019-236.39
2018-167.94
2017-90.25
2016-48.36
2015-39.35
20148.93
201394.47
2012128.36